Medpace Holdings, Inc. (MEDP) Comparison with companies in other sectors?

Medpace Holdings, Inc. has a share price of 28.09M. You can analyze Medpace Holdings, Inc. (MEDP) competitors across different market sectors through stock heatmaps.

What are MEDP's NET and operating margins?

Medpace Holdings, Inc. (MEDP) operating margin is around 0.21, and net profit margin is approximately 0.19 as of the latest reports.

In what way does MEDP's earnings per share (EPS) trend reflect its financial momentum?

Medpace Holdings, Inc. (MEDP) EPS is 13.46 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Medpace Holdings, Inc. is 33.28, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Medpace Holdings, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Medpace Holdings, Inc. like P/E which is 31.60, P/B which is 76.68, and PEG which is 13.77. Compare them with sector averages to evaluate if the stock is priced fairly.

Medpace Holdings, Inc.

MEDP•NASDAQ

Healthcare

Medical - Diagnostics & Research

$447.92

$-5.13(-1.13%)

Medpace Holdings, Inc. (MEDP) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$13.46

P/E Ratio

33.28

ROE

0.68%

Net Margin

0.19%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$12.58B

Shares OutstandingTotal number of shares issued

$28.09M

Book Value/ShareNet worth per share

$5.84

Revenue/ShareAnnual revenue per share

$75.68

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$13.46

Net MarginNet income as percentage of revenue

18.74%

Operating MarginOperating income as percentage of revenue

21.40%

ROEReturn on shareholders' equity

67.66%

ROAReturn on total assets

26.61%

ROCEReturn on capital employed

135.95%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$20.21

Cash/ShareCash and equivalents per share

$1.57

FCF YieldFree cash flow as percentage of market cap

4.73%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for MEDPFinancial Ratios Analysis details for MEDP are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for MEDPSector Benchmarking details for MEDP are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Medpace Holdings, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Medpace Holdings, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Medpace Holdings, Inc.'s unique business strengths and challenges.

Key Financial Metrics for Medpace Holdings, Inc.

For Medpace Holdings, Inc., essential financial indicators include EPS 13.46, PE 33.28, and ROE 0.68. These key ratios reveal insights into Medpace Holdings, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Medpace Holdings, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Medpace Holdings, Inc.

Metrics like Net Margin 18.74% and ROA 26.61% shed light on how well Medpace Holdings, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Medpace Holdings, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Medpace Holdings, Inc.

Using ratios such as P/B Ratio 76.68 and PEG Ratio 13.77, investors can assess whether Medpace Holdings, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Medpace Holdings, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Medpace Holdings, Inc.

Financial health indicators, such as Debt/Equity Ratio 0.72 and Cash Flow $20.21, provide a snapshot of Medpace Holdings, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Medpace Holdings, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Medpace Holdings, Inc.

Investing in Medpace Holdings, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Medpace Holdings, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;